Good morning, and welcome to another working week. Elizabeth Cooney here, filling in for the vacationing Ed Silverman from STAT’s global HQ in Boston, where the coffee is never flavored. We welcome your comments, suggestions, and especially your tips.

Flu vaccine may have to be airlifted into Britain to prevent a winter crisis in the event of a no-deal Brexit, according to the largest producer of the shots, the Times of London notes. Hugo Fry, U.K. chief of the French drugs giant Sanofi (SNY), said the extreme measure may be needed because of the threat of crucial supplies being stuck in long lines at the British border. Sanofi, which distributes the vaccine by trucks from Normandy, has decided to increase its drug stockpile in case Britain fails to secure a trade deal before leaving the E.U. in March. But vaccine for winter 2019-20 wouldn’t be added to those reserves because it normally arrives in the U.K. in the preceding August.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy